Jungu Biomedical Device Co., Ltd
Update：2026/09/15
Industries
Main Industry
Health Care
Main Product/Service
Jungu Biomedical Device Co., Ltd is dedicated to the research and development of "Zhuiwenqiang", a spinal stabilization device designed for minimally invasive surgery. Compared to existing products currently on the market, this product offers the following advantages:
1. Suitable for minimally invasive surgery;
2. Effective tension levels can prevent adjacent segment disease;
3. Can be completed in a single procedure, eliminating the need for a second surgery;
4. Easy to operate, helping spinal patients receive better medical care through innovative medical devices.
(The content above was translated by AI.)
1. Suitable for minimally invasive surgery;
2. Effective tension levels can prevent adjacent segment disease;
3. Can be completed in a single procedure, eliminating the need for a second surgery;
4. Easy to operate, helping spinal patients receive better medical care through innovative medical devices.
(The content above was translated by AI.)
Founded Year
2022
Unified Business No.
89129492
Status
Active
Number of Employees
0
Total Paid-in
Capital
29,466,670 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Jungu Biomedical Device Co., Ltd was co-founded by three founders in December 2022. Among them, Meng-Huang Wu is an assistant professor in the Department of Orthopedics at Taipei Medical University (TMU) and the director of the Division of Spinal Surgery in the Department of Orthopedics at the university's affiliated hospital, specializing in minimally invasive spinal fusion surgery, and also serves as the CEO of the TMU Biodesign Center, dedicated to combining academic and clinical technologies and successfully commercializing them. Kai-Hung Hsieh holds a master's degree from the Institute of Biomedical Engineering at National Yang-Ming University and previously served as an R&D engineer at United Orthopedic Corporation. Chia-Hsuan Lee also holds a master's degree from the Institute of Biomedical Engineering at National Yang-Ming University and previously worked at Amed Co., Ltd. Jungu Biomedical Device Co., Ltd is a medical device manufacturer dedicated to the research, development, and sale of medical devices suitable for minimally invasive surgery, aiming to provide spinal stability and effectively improve adjacent segment disease through its core philosophy of "minimally invasive, rapid, and simple."
(The content above was translated by AI.)
(The content above was translated by AI.)
